These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Delineation of the functional properties and the mechanism of action of AA29504, an allosteric agonist and positive allosteric modulator of GABA Olander ER; Madjroh N; Bunch L; Söderhielm PC; Jensen AA Biochem Pharmacol; 2018 Apr; 150():305-319. PubMed ID: 29454619 [TBL] [Abstract][Full Text] [Related]
8. GABAA receptor subtype-selective modulators. II. α5-selective inverse agonists for cognition enhancement. Atack JR Curr Top Med Chem; 2011; 11(9):1203-14. PubMed ID: 21050171 [TBL] [Abstract][Full Text] [Related]
10. Orthosteric and benzodiazepine cavities of the α Amundarain MJ; Viso JF; Zamarreño F; Giorgetti A; Costabel M J Biomol Struct Dyn; 2019 Apr; 37(6):1597-1615. PubMed ID: 29633901 [TBL] [Abstract][Full Text] [Related]
11. Development and SAR of functionally selective allosteric modulators of GABAA receptors. Alhambra C; Becker C; Blake T; Chang AH; Damewood JR; Daniels T; Dembofsky BT; Gurley DA; Hall JE; Herzog KJ; Horchler CL; Ohnmacht CJ; Schmiesing RJ; Dudley A; Ribadeneira MD; Knappenberger KS; Maciag C; Stein MM; Chopra M; Liu XF; Christian EP; Arriza JL; Chapdelaine MJ Bioorg Med Chem; 2011 May; 19(9):2927-38. PubMed ID: 21498079 [TBL] [Abstract][Full Text] [Related]
12. The efficacy of γ-aminobutyric acid type A receptor (GABA Mundy PC; Pressly B; Carty DR; Yaghoobi B; Wulff H; Lein PJ Toxicol Appl Pharmacol; 2021 Sep; 426():115643. PubMed ID: 34265354 [TBL] [Abstract][Full Text] [Related]
13. Comparative effects of nonselective and subtype-selective gamma-aminobutyric acidA receptor positive modulators in the rat-conditioned emotional response test. Mathiasen LS; Rodgers RJ; Mirza NR Behav Pharmacol; 2007 May; 18(3):191-203. PubMed ID: 17426483 [TBL] [Abstract][Full Text] [Related]
14. A Pharmacogenetic 'Restriction-of-Function' Approach Reveals Evidence for Anxiolytic-Like Actions Mediated by α5-Containing GABAA Receptors in Mice. Behlke LM; Foster RA; Liu J; Benke D; Benham RS; Nathanson AJ; Yee BK; Zeilhofer HU; Engin E; Rudolph U Neuropsychopharmacology; 2016 Sep; 41(10):2492-501. PubMed ID: 27067130 [TBL] [Abstract][Full Text] [Related]
15. The benzodiazepine binding site of GABA(A) receptors as a target for the development of novel anxiolytics. Atack JR Expert Opin Investig Drugs; 2005 May; 14(5):601-18. PubMed ID: 15926867 [TBL] [Abstract][Full Text] [Related]
16. Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Rudolph U; Crestani F; Benke D; Brünig I; Benson JA; Fritschy JM; Martin JR; Bluethmann H; Möhler H Nature; 1999 Oct; 401(6755):796-800. PubMed ID: 10548105 [TBL] [Abstract][Full Text] [Related]
18. The GABAA-BZR complex as target for the development of anxiolytic drugs. Trincavelli ML; Da Pozzo E; Daniele S; Martini C Curr Top Med Chem; 2012; 12(4):254-69. PubMed ID: 22204488 [TBL] [Abstract][Full Text] [Related]
19. Sustained treatment with an α5 GABA A receptor negative allosteric modulator delays excitatory circuit development while maintaining GABAergic neurotransmission. Nuwer JL; Brady ML; Povysheva NV; Coyne A; Jacob TC Neuropharmacology; 2021 Oct; 197():108724. PubMed ID: 34284042 [TBL] [Abstract][Full Text] [Related]
20. GABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam. Sankar R CNS Drugs; 2012 Mar; 26(3):229-44. PubMed ID: 22145708 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]